Invest1 distinct publisher3 min readUpdated
Bill C-15 puts equipment back in scope for SR&ED and doubles the enhanced credit ceiling to $6 million. Xanadu's $302 million USD dual listing is the harder experiment.
The Investor · Invest desk

Compiled by The InvestorSomething wrong?How this is made
Canada's budget legislation put physical property back inside the country's largest R&D subsidy, and in the same month Xanadu raised $302 million USD in gross proceeds on the Toronto Stock Exchange and Nasdaq [7][1]. Both events respond to the same structural problem: a company building photonic quantum computers may be years away from a commercially useful system and the revenue it would generate, which is longer than most private capital is patient for [2].
The tax side is the more concrete of the two. SR&ED returns an average of more than $4.4 billion a year to over 19,000 claimants as non-dilutive capital against the cost of experimentation [4], which works out to roughly $230,000 per claimant [5]. For more than a decade that money skewed toward software, because capital costs had been stripped out of the program, leaving companies doing physical R&D able to claim wages and materials but little of the property the work actually required [6]. Bill C-15, which became law in March, restores capital expenditure eligibility for qualifying property acquired on or after Dec. 16, 2024 [7]. It also doubles the annual spending limit for the enhanced refundable credit from $3 million to $6 million, lifting the maximum federal refund at the 35-percent rate from $1.05 million to $2.1 million [8][9], an increase of $1.05 million [10]. Eligible Canadian public companies can access the enhanced credit for the first time [11].
That last clause is the one worth sitting with. A pre-revenue deep tech company that lists to reach a longer-duration capital pool no longer gives up the enhanced refundable credit to do it [11]. Set against Xanadu's raise, though, the credit is a rounding item: $2.1 million is about 0.7 percent of $302 million, even before accounting for the fact that the listing was priced in US dollars [17]. SR&ED does not replace investors or grants, and the money arrives only after eligible work is completed, according to Paul Davenport, head of content at the Canadian R&D tax credit platform Boast [12]. His framing of the mismatch is blunt: "Venture capital is built to reward speed and reduce risk quickly. Tough tech is the opposite of that on both counts" [3]. Note the interest: the only named expert in the source works for a company that files these claims [18].
The practical caution is that eligibility turns on when property was acquired, how it was used, and whether that use ties directly to eligible research, not simply on what was bought [19]. Davenport says the largest misconception is assuming the change is automatic [14], and suggests starting with major capital purchases from the past 12 to 18 months, flagging specialized equipment, prototyping tools or pilot-line infrastructure acquired after the eligibility date [15]. Companies with filings already underway should check whether affected tax years can absorb the newly eligible spending rather than deferring it [16].
What to watch: whether Xanadu trades well enough after being the first Canadian tech firm to list on the TSX since 2021 [1] to make the venue credible for the next pre-revenue hard-science issuer, and whether the December 2024 acquisition date [7] shows up as pulled-forward capex in the next round of claims. A retroactive credit rewards companies that already bought the equipment. It does not, on its own, finance the ones that have not.
Follow any of these and your For You feed starts watching them — no settings page required.
Ranked by verification strength, evidence, and original report placement.
Xanadu's March debut on the Toronto Stock Exchange and Nasdaq made it the first Canadian tech firm to list on the TSX since 2021, raising $302 million USD in gross proceeds.
Xanadu is building photonic quantum computers designed to solve problems beyond today's capacity, and attracted that investment while a commercially useful system and the revenue it could generate may still be years away.
"Venture capital is built to reward speed and reduce risk quickly. Tough tech is the opposite of that on both counts."
SR&ED is Canada's largest federal R&D support program, returning on average more than $4.4 billion in tax credits to over 19,000 claimants every year as non-dilutive capital to offset the cost of experimentation.
Capital costs were removed from SR&ED more than a decade ago, leaving companies doing physical R&D able to claim eligible wages and materials but not much of the property needed to carry out the work; the program was often considered a better fit for software and SaaS.
Bill C-15, the federal budget legislation that became law in March, restores capital expenditure eligibility for qualifying property acquired on or after Dec. 16, 2024.
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
Single sponsored source, specific but uncorroborated figures
Every factual element rests on one publisher item, which is labelled sponsored content and quotes only the sponsor's head of content. The legislative specifics are precise and checkable in principle (Bill C-15, Dec. 16, 2024 acquisition date, $3M to $6M limit, $1.05M to $2.1M refund), which lifts the score above the floor, but no statute text, tax authority guidance, accounting firm, or second publisher is present in the cluster to verify any of them, and the Xanadu listing details are asserted rather than sourced.
Policy in force, uptake of the new capital rules unobserved
Two concrete real-world events anchor the low-to-middle score: the legislation is enacted rather than proposed, and Xanadu's dual listing actually closed with $302 million USD raised. A pre-existing program baseline of more than 19,000 annual claimants shows the delivery channel is widely used. What is entirely absent is any observation of adoption of the change itself, no company claiming restored capital costs, no refund received at the new $2.1 million ceiling, and no public company using the enhanced credit for the first time.
Modestly overstated: real rule change, promotional framing
The underlying policy facts appear to be a genuine, specific change, so this is not manufactured news. The overstatement is in framing and scale. A sponsored article headlined as a break for deep tech extends from a $302 million USD quantum listing to a credit whose enhanced ceiling tops out at $2.1 million, roughly 0.7 percent of that raise, and whose refunds arrive only after work is completed. The article's own expert concedes the change is not automatic and will not replace investors or grants, which pulls the gap back toward alignment rather than far into overstatement.
Vendor-sponsored piece promoting the sponsor's own service
The article is explicitly presented by Boast, the sole quoted expertise is Boast's head of content, Boast's claim-preparation service is described in the body, and the piece ends with a call to talk to a Boast SR&ED expert. The commercial interest is disclosed, which is why this is not scored at the ceiling, but the alignment between the editorial thesis (review your receipts, make SR&ED part of the financing plan) and the sponsor's revenue model is close to total.
Moderate-low: checkable specifics, no independent verification
Confidence is limited by the one-source, sponsor-shaped evidence base and by soft dating (events given only as 'March'), and by unstated currency for the credit figures. It is not lower because the legislative and program figures are unusually specific and internally consistent, the sponsorship is disclosed rather than hidden, and the sponsor's own caveats about non-automatic eligibility reduce the risk that the core policy facts are inflated.
invest
IPO proceeds tripled to $205.1B, but the deal count barely moved1 distinct publisher
build
The $559M-versus-$12.3B quarter matters more than the $65B run rate4 distinct publishers
invest
Klarna's $1bn Quarter: Margin Dollars Up 42%, Revenue Up 27%, And That Gap Is The Story2 distinct publishers
leadership
AI capex outgrew the consumer. Your demand forecast is now an AI bet.1 distinct publisher
Distinct publishers with included, body-backed reporting in this cluster.
1 article · August 18, 2026